LYC-001
N/A
Report date: 2026/01/21 20:00:47
Base Information
Drug NameLYC-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Liangyuan Bioscience Llc
China Registration ClassN/A
Develop Information
Active CompaniesCancer Hospital Of Chinese Academy Of Medical SciencesBeijing Liangyuan Bioscience Llc
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A